Lantheus Holdings (LNTH) Inventory Average (2015 - 2026)
Lantheus Holdings (LNTH) posted quarterly Inventory Average of $63.0 million for Q1 2026, down 8.12% year-over-year from $68.6 million in Q1 2025, and down 0.55% quarter-over-quarter from $63.4 million in Q4 2025.
Lantheus Holdings (LNTH) Inventory Average (2015 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has reported Inventory Average for 12 consecutive years, with $63.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Inventory Average fell 8.12% year-over-year to $63.0 million; the TTM figure through Mar 2026 stood at $63.0 million (down 8.12% YoY), while the FY2025 annual figure was $66.3 million, changed 0.49% from the prior year.
- Inventory Average fell to $63.0 million in Q1 2026 per LNTH's latest filing, from $63.4 million in the prior quarter.
- Across five years, Inventory Average topped out at $70.7 million in Q3 2024 and bottomed at $34.1 million in Q2 2022.
- Historically, Inventory Average has averaged $55.2 million across 5 years, with a median of $62.1 million in 2025.
- Annual changes were most pronounced in 2024 — Inventory Average soared 72.34% — and 2025, when it dropped 12.14%.
- Lantheus Holdings' Inventory Average stood at $35.1 million in 2022, then jumped by 71.47% to $60.2 million in 2023, then increased by 15.25% to $69.4 million in 2024, then slipped by 8.75% to $63.4 million in 2025, then dropped by 0.55% to $63.0 million in 2026.
- Business Quant data shows LNTH's Inventory Average at $63.0 million in Q1 2026, $63.4 million in Q4 2025, and $62.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 1.41 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 3.20 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 2.56 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 8.99 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 186.05 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 3.93 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 84.35 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.74 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 824.00 Mn |
| 10 | Lantheus Holdings | 6.54 Bn | 5.94 Bn | 241.86 Mn | 59.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 59.45 Mn |
| Mar 31, 2026 | 63.01 Mn |
| Dec 31, 2025 | 63.36 Mn |
| Sep 30, 2025 | 62.10 Mn |
| Jun 30, 2025 | 65.64 Mn |
| Mar 31, 2025 | 68.58 Mn |
| Dec 31, 2024 | 69.43 Mn |
| Sep 30, 2024 | 70.68 Mn |
| Jun 30, 2024 | 70.14 Mn |
| Mar 31, 2024 | 66.89 Mn |
| Dec 31, 2023 | 60.25 Mn |
| Sep 30, 2023 | 54.13 Mn |
| Jun 30, 2023 | 46.98 Mn |
| Mar 31, 2023 | 38.82 Mn |
| Dec 31, 2022 | 35.13 Mn |
| Sep 30, 2022 | 34.38 Mn |
| Jun 30, 2022 | 34.10 Mn |
| Mar 31, 2022 | 34.69 Mn |
| Dec 31, 2021 | 34.54 Mn |
| Sep 30, 2021 | 32.83 Mn |